SEC Filings for Genetic Technologies Ltd (GENE)

$ 2.35   -0.06 (-2.49%) Volume: 598.07k 4:00 PM EDT Jul 10, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934606/19/2020
SC 13GStatement of acquisition of beneficial ownership by individuals806/04/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934606/04/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934706/03/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934506/03/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934606/03/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19346405/29/2020
424B4Prospectus [Rule 424(b)(4)]15705/28/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934505/19/2020
F-1/A[Amend] Registration statement for certain foreign private issuers24205/12/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341204/30/2020
SC 13GStatement of acquisition of beneficial ownership by individuals804/28/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934404/24/2020
<<
First
<
Prev
123456789101112131415